Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started
My Medicine

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Pancreatic Cancer Health Center

Font Size

FDA OKs New Pancreatic Cancer Treatment

Lung Cancer Drug Tarceva Cleared to Help Treat Advanced Disease
WebMD Health News
Reviewed by Louise Chang, MD

Nov. 7, 2005 -- The FDA has approved the use of the lung cancer drug Tarceva to treat advanced pancreatic cancer.

Tarceva was cleared for use in combination with Gemzar (gemcitabine), a chemotherapy drug, which is used to treat pancreatic cancer.

Pancreatic cancer is the No. 4 cause of cancer deaths in the U.S.

Tarceva's new use focuses on pancreatic cancer patients who haven't had chemotherapy before and whose disease is locally advanced or has spread to other parts of the body.

About Tarceva

Tarceva is a pill. It's designed to block tumor cell growth. To do that, it targets a receptor on some cell surfaces called human epidermal growth factor receptor 1.

Tarceva is already used as a treatment for the most common type of lung cancer -- nonsmall cell lung cancer.

The FDA approved Tarceva for pancreatic cancer based on a study of 569 pancreatic cancer patients. The study was a phase III clinical trial -- the last type of trial required for new drug treatments by the FDA.

Half of the patients took Tarceva and Gemzar. The others took Gemzar and an empty drug (placebo). The patients didn't know whether they'd gotten Tarceva.

A year later, 24% of the Tarceva group was still alive, compared with 19% of those who didn't take Tarceva.

Side Effects

Rash and diarrhea were seen more often in the Tarceva group than with the placebo. Few patients quit the trial over those side effects.

More severe -- and much rarer -- side effects with Tarceva can include:

Women taking Tarceva should avoid becoming pregnant or breastfeeding.

Tarceva is marketed in the U.S. by OSI Pharmaceuticals and Genentech BioOncology. OSI Pharmaceuticals has licensed Roche to market Tarceva outside the U.S. Genentech and Roche are WebMD sponsors.

Today on WebMD

human pancreas
Do you know what they are?
man with a doctor
Our health check will steer you in the right direction.
sauteed cherry tomatoes
Fight cancer one plate at a time.
Lung cancer xray
See it in pictures, plus read the facts.
Integrative Medicine Cancer Quiz
Patrick Swayzes Widow Healing From Loss
Pets Improve Your Health
Resolved To Quit Smoking